Pricing Log in Create free account

Azitra, Inc. (AZTR) vs Dermata Therapeutics, Inc. (DRMA)

Azitra, Inc. and Dermata Therapeutics, Inc. are both Biotechnology companies. Azitra, Inc. and Dermata Therapeutics, Inc. are of similar size ($4.5M and $4.3M). Dermata Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Azitra, Inc. trades at 1.0×. Across the 10 metrics below, Dermata Therapeutics, Inc. leads on 6 and Azitra, Inc. on 4.

Valuation

Metric AZTR DRMA Biotechnology median
P/E 1.05 n/m 8.50
P/S 2.33 n/m 9.71
P/B 0.18 0.99 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.48 0.03 0.64
EV/Sales (9.26) n/m 9.21
Earnings yield 95.57% (510.47%) (33.15%)
Free cash flow yield (842.70%) (232.27%) (25.50%)

Profitability

Metric AZTR DRMA Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (256.67%) (183.89%) (56.36%)
Return on assets (190.69%) (139.93%) (48.04%)
Return on invested capital (1,272.49%) 0.00% 0.00%

Growth

Metric AZTR DRMA Biotechnology median
Revenue growth (TTM) 58.18% — 6.02%
EPS growth (last fiscal year) 85.67% 89.84% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AZTR DRMA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.86 2.81 4.72
Net debt to EBITDA 0.20 0.97 0.96

Dividend

Metric AZTR DRMA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AZTR DRMA Biotechnology median
Market cap 4.33m 4.51m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack